Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia. [electronic resource]
Producer: 20181001Description: 2127 p. digitalISSN:- 2041-1723
- Antineoplastic Agents -- therapeutic use
- Biopsy
- Child
- Child, Preschool
- DNA Methylation
- Disease-Free Survival
- Female
- Genome, Human -- genetics
- Hematopoietic Stem Cell Transplantation
- Humans
- Infant
- Kaplan-Meier Estimate
- Leukemia, Myelomonocytic, Juvenile -- blood
- Male
- Monocytes
- Mutation
- Neoplasm Regression, Spontaneous -- genetics
- Prognosis
- Prospective Studies
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.